Literature DB >> 17112812

Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent.

Petra A Thürmann, Sara Haack, Ulrike Werner, Jacek Szymanski, Grit Haase, Bernd Drewelow, Ilselore R Reimann, Marion Hippius, Werner Siegmund, Karen May, Joerg Hasford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112812     DOI: 10.1016/j.clpt.2006.08.004

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

Review 1.  Hypertension Across a Woman's Life Cycle.

Authors:  Nanette K Wenger; Anita Arnold; C Noel Bairey Merz; Rhonda M Cooper-DeHoff; Keith C Ferdinand; Jerome L Fleg; Martha Gulati; Ijeoma Isiadinso; Dipti Itchhaporia; KellyAnn Light-McGroary; Kathryn J Lindley; Jennifer H Mieres; Mary L Rosser; George R Saade; Mary Norine Walsh; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2018-04-24       Impact factor: 24.094

2.  Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments.

Authors:  Sven Schmiedl; Marietta Rottenkolber; Jacek Szymanski; Werner Siegmund; Marion Hippius; Katrin Farker; Bernd Drewelow; Joerg Hasford; Petra Thürmann
Journal:  Dtsch Arztebl Int       Date:  2013-04-05       Impact factor: 5.594

3.  Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia.

Authors:  Kosuke Doki; Masato Homma; Keisuke Kuga; Kazutaka Aonuma; Satoshi Sakai; Iwao Yamaguchi; Yukinao Kohda
Journal:  Eur J Clin Pharmacol       Date:  2007-07-31       Impact factor: 2.953

4.  Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rate.

Authors:  Angela Seeringer; Jürgen Brockmöller; Steffen Bauer; Julia Kirchheiner
Journal:  Eur J Clin Pharmacol       Date:  2008-06-11       Impact factor: 2.953

5.  Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI).

Authors:  Ksenia Goryachkina; Aleksandra Burbello; Svetlana Boldueva; Svetlana Babak; Ulf Bergman; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2007-11-29       Impact factor: 2.953

6.  CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction.

Authors:  Ksenia Goryachkina; Aleksandra Burbello; Svetlana Boldueva; Svetlana Babak; Ulf Bergman; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2008-07-22       Impact factor: 2.953

Review 7.  Gender Differences in Cardiovascular Pharmacotherapy-the Example of Hypertension: A Mini Review.

Authors:  Jacklean Kalibala; Antoinette Pechère-Bertschi; Jules Desmeules
Journal:  Front Pharmacol       Date:  2020-05-06       Impact factor: 5.810

8.  Sex-Based Difference in the Effect of Metoprolol on Heart Rate and Bradycardia in a Population-Based Setting.

Authors:  Linda C Hendriksen; Grace Omes-Smit; Birgit C P Koch; M Arfan Ikram; Bruno H Stricker; Loes E Visser
Journal:  J Pers Med       Date:  2022-05-25

Review 9.  Sex differences in hypertension. Do we need a sex-specific guideline?

Authors:  Renata Cífková; Larysa Strilchuk
Journal:  Front Cardiovasc Med       Date:  2022-08-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.